FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Börse Stuttgart 20:41:57 10/05/2024 BST | ||
| 4.62 EUR | +3.12% |
|
| Current month | -51.72% | ||
| 1 month | -58.08% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 4.62 | +3.12% | 0 |
| 09/05/24 | 4.48 | -10.22% | 0 |
| 08/05/24 | 4.99 | -7.59% | 0 |
| 07/05/24 | 5.4 | -0.92% | 0 |
| 06/05/24 | 5.45 | +10.32% | 0 |
Delayed Quote Börse Stuttgart
Last update May 10, 2024 at 08:41 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MG0PBE |
| ISIN | DE000MG0PBE5 |
| Date issued | 22/03/2024 |
| Strike | 391.1 $ |
| Maturity | Unlimited |
| Parity | 15.92 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.78 € |
|---|---|
| Lowest since issue | 3.77 € |
| Spread | 0.02 € |
| Spread % | 0.42% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat
